Louisiana State University patents new 5-HT2 receptor ligands
Feb. 24, 2023
Louisiana State University has disclosed 5-HT2 receptor ligands reported to be useful for the treatment of anxiety, depression, asthma, chronic obstructive pulmonary disease (COPD), Alzheimer's disease, rheumatoid arthritis, chronic pain and post-stress traumatic disorder, among others.